NCT05172232View on ClinicalTrials.gov

Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions

CompletedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

January 23, 2023

Study Completion Date

January 23, 2023

Conditions
Malignant Melanoma
Interventions
DIAGNOSTIC_TEST

Dermalyzer

To evaluate the diagnostic accuracy of the Dermalyzer device to detect melanoma among cutaneos skin lesions by dermoscopy.

Trial Locations (3)

58185

Region Östergötland Primary Care, Linköping

Unknown

Region Stockholm Primary Care, Stockholm

Region Kalmar and Kronoberg, Vaxjo

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Region Östergötland

OTHER

collaborator

Region Stockholm

OTHER_GOV

collaborator

Landstinget i Kalmar Län

OTHER

collaborator

Kronoberg County Council

OTHER_GOV

lead

Linkoeping University

OTHER_GOV